Cost-Efficacy of Individual and Combined Treatments for Panic Disorder
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The objective of this study was to examine the relative cost-efficacy of empirically supported treatments for panic disorder. As psychosocial, pharmacologic, and combined treatments have all demonstrated efficacy in the treatment of panic disorder, cost-efficacy analysis provides an additional source of information to guide clinical decision making. METHOD: Cost-efficacy was examined based on results from the Multicenter Comparative Treatment Study of Panic Disorder, a randomized controlled trial of treatment for panic disorder (DSM-III-R). The trial was conducted from May 1991 to April 1998. Cost-efficacy ratios representing the cost per 1-unit improvement in Panic Disorder Severity Scale mean item score were calculated for 3 monotherapies (cognitive-behavioral therapy [CBT], imipramine, and paroxetine) and 2 combination treatments (CBT-imipramine and CBT-paroxetine) at the end of acute, maintenance, and follow-up phases. RESULTS: Results demonstrated consistently greater cost-efficacy for individual over combined treatments, with imipramine representing the most cost-efficacious treatment option at the completion of the acute phase (cost-efficacy ratio = $972) and CBT representing the most cost-efficacious option at the end of maintenance treatment (cost efficacy ratio = $1449) and 6 months after treatment termination (cost-efficacy ratio = $1227). CONCLUSION: In the context of similar efficacy for combined treatments, but poorer cost-efficacy, current monotherapies should be considered the first-line treatment of choice for panic disorder. Additionally, CBT emerged as the most durable and cost-effective monotherapy and, hence, should be considered as a particularly valuable treatment from the perspective of cost accountability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-010-0319-7 · Cited by 8,721
“These cost estimations are combined with patient outcomes and used in cost-effectiveness studies (McHugh et al. 2007).”
BackgroundMcHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“, 2009), monotherapies (McHugh et al., 2007) and self-directed approaches (McCrone et al.”
BackgroundInfluentialBaker, T. B., McFall, R. M., & Shoham, V. (2008) · Psychological Science in the Public Interest · doi:10.1111/j.1539-6053.2009.01036.x · Cited by 342
Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
Otto, M. W., Tolin, D. F., Simon, N. M., Pearlson, G. D., Basden, S., Meunier, S. A., Hofmann, S. G., Eisenmenger, K., Krystal, J. H., & Pollack, M. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.036 · Cited by 251
Self-citationComer, J. S., Blanco, C., Hasin, D. S., Liu, S.-M., Grant, B. F., Turner, J. B., & Olfson, M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05094blu · Cited by 214
Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: A systematic review
Konnopka, A., Leichsenring, F., Leibing, E., & König, H.-H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.014 · Cited by 161
“For 6 studies an ICER could be derived from the reported data (Issakidis et al., 2004; Katon et al., 2006; Jorgensen et al., 2006; Kolbasovsky et al., 2007; McHugh et al., 2007; Roberge et al., 2008).”
BackgroundMethodInfluentialEmpirically Supported Treatments for Panic Disorder
McHugh, R. K., Smits, J. A. J., & Otto, M. W. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.05.005 · Cited by 106
Self-citationOtto, M. W., McHugh, R. K., Simon, N. M., Farach, F. J., Worthington, J. J., & Pollack, M. H. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.04.002 · Cited by 95
Self-citationMeasures for Predictors of Innovation Adoption
Chor, K. H. B., Wisdom, J. P., Olin, S.-C. S., Hoagwood, K. E., & Horwitz, S. M. (2015) · Administration and Policy in Mental Health and Mental Health Services Research · doi:10.1007/s10488-014-0551-7 · Cited by 85
“A fourth approach uses administrative data on service reimbursement rates to compare the cost-efficacy ratios across EBPs to aid adoption decision-making (McHugh et al. 2007).”
BackgroundOtto, M. W., Tolin, D. F., Nations, K. R., Utschig, A. C., Rothbaum, B. O., Hofmann, S. G., & Smits, J. A. J. (2012) · Depression and Anxiety · doi:10.1002/da.21910 · Cited by 54
“This relationship is particularly clear in panic disorder,[10, 11] and with the costs of treatment determined most obviously by the number of sessions required for a treatment response, a more efficient intervention translates to a markedly lower direct cost.”
BackgroundSelf-citationCost‐effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder
van Apeldoorn, F. J., Stant, A. D., van Hout, W. J. P. J., Mersch, P. P. A., & den Boer, J. A. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12169 · Cited by 19
Tzavela, E. C., Mitskidou, P., Mertika, A., Stalikas, A., & Kasvikis, Y. (2018) · Psychotherapy Research · doi:10.1080/10503307.2016.1246769 · Cited by 13
A Comparison between Psychosocial and Pharmacological Treatments
Powers, M. B., Kauffman, B. Y., Diamond, A., & Smits, J. A. J. (2014) · Social Anxiety · doi:10.1016/b978-0-12-394427-6.00026-1 · Cited by 3
Metadata
- Authors
- McHugh, R. K., Otto, M. W., Barlow, D. H., Gorman, J. M., Shear, K., & Woods, S. W.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-07-15
- Volume
- 68
- Issue
- 07
- Pages
- 1038-1044
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1995287141
- Cited by
- 68
- References
- 0
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.